Announce Date | 06/24/2025 |
EPS Normalized Actual | $6.07 (Beat by $0.25) |
EPS GAAP Actual | $6.07 (Beat by $0.25) |
Revenue Actual | $22.22B |
Revenue Surprise | Beat by $22220M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
May 2030 | 34.18515 | 6.91 | 32.83015 | 35.90236 | 2 |
May 2029 | 35.3379 | 6.68 | 33.62465 | 36.42168 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 6.88 | 6.88 | 22.22B | 0.5% | 22220M |
FQ1 2025 (Feb 2025) | 3.79 | 3.79 | 22.16B | 1.9% | 22160M |
FQ4 2024 (Nov 2024) | 3.07 | 3.07 | 21.967B | -0.9% | 21967M |
FQ3 2024 (Aug 2024) | 3.21 | 3.21 | 21.579B | -0.47% | 21579M |
FQ2 2024 (May 2024) | 0 | 0 | 22.109B | 0.81% | 22109M |
FQ1 2024 (Feb 2024) | 3.55 | 3.55 | 21.738B | -1.98% | 21738M |
FQ4 2023 (Nov 2023) | 3.59 | 3.59 | 22.165B | -2.93% | 22165M |
FQ3 2023 (Aug 2023) | 4.28 | 4.28 | 21.681B | -7.2% | 21681M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Nov 2029) | 7.7573 | -- | 7.5886 | 7.96339 | 10 |
FQ3 2029 (Aug 2029) | 6.5946 | -- | 6.45119 | 6.7698 | 10 |
FQ2 2029 (May 2029) | 9.33 | -- | 8.96407 | 9.59525 | 9 |
FQ1 2029 (Feb 2029) | 7.2551 | -- | 6.97055 | 7.46136 | 9 |
FQ4 2028 (Nov 2028) | 6.8764 | -- | 6.6067 | 7.07189 | 10 |
FQ3 2028 (Aug 2028) | 6.6606 | -- | 6.39937 | 6.84996 | 10 |
FQ2 2028 (May 2028) | 7.9761 | -- | 7.66327 | 8.20286 | 10 |
FQ1 2028 (Mar 2028) | 6.877 | -- | 6.74736 | 7.11307 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2029 (Nov 2029) | 25.58B | -- | 25.15B | 26.11B | 9 |
FQ3 2029 (Aug 2029) | 24.97B | -- | 24.56B | 25.48B | 9 |
FQ2 2029 (May 2029) | 26.2B | -- | 25.41B | 26.77B | 9 |
FQ1 2029 (Feb 2029) | 25.85B | -- | 25.07B | 26.42B | 13 |
FQ4 2028 (Nov 2028) | 25.88B | -- | 25.1B | 26.45B | 13 |
FQ3 2028 (Aug 2028) | 25.47B | -- | 24.7B | 26.03B | 17 |
FQ2 2028 (May 2028) | 25.07B | -- | 24.31B | 25.62B | 8 |
FQ1 2028 (Mar 2028) | 24.68B | -- | 24.32B | 25.33B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 6.88 | 6.88 | 100% | |
FQ1 2025 (Feb 2025) | 3.79 | 3.79 | 100% | |
FQ4 2024 (Nov 2024) | 3.07 | 3.07 | 100% | |
FQ3 2024 (Aug 2024) | 3.21 | 3.21 | 100% | |
FQ2 2024 (May 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Feb 2024) | 3.55 | 3.55 | 100% | |
FQ4 2023 (Nov 2023) | 3.59 | 3.59 | 100% | |
FQ3 2023 (Aug 2023) | 4.28 | 4.28 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $22.22B | $22220M | 100% |
FQ1 2025 (Feb 2025) | $0B | $22.16B | $22160M | 100% |
FQ4 2024 (Nov 2024) | $0B | $21.97B | $21967M | 100% |
FQ3 2024 (Aug 2024) | $0B | $21.58B | $21579M | 100% |
FQ2 2024 (May 2024) | $0B | $22.11B | $22109M | 100% |
FQ1 2024 (Feb 2024) | $0B | $21.74B | $21738M | 100% |
FQ4 2023 (Nov 2023) | $0B | $22.17B | $22165M | 100% |
FQ3 2023 (Aug 2023) | $0B | $21.68B | $21681M | 100% |